Alessandra Daigneault's Insider Trades & SAST Disclosures
Alessandra Daigneault's most recent trade in NRX Pharmaceuticals Inc was a trade of 43,000 Employee Stock Option (Right to buy) done . Disclosure was reported to the exchange on Aug. 19, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Alessandra Daigneault.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | 19 Aug 2021 | 43,000 | 100,840 | - | - | Employee Stock Option (Right to buy) | ||
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 13.11 per share. | 19 Aug 2021 | 33,715 | 0 | - | 13.1 | 442,004 | Common Stock |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | 19 Aug 2021 | 28,916 | 71,924 | - | - | Employee Stock Option (Right to buy) | ||
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. | 19 Aug 2021 | 27,395 | 33,715 | - | 3.1 | 84,103 | Common Stock |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | 19 Aug 2021 | 20,666 | 28,934 | - | - | Employee Stock Option (Right to buy) | ||
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. | 19 Aug 2021 | 18,420 | 18,420 | - | 3.1 | 56,549 | Common Stock |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 15,605 | 15,605 | - | - | Restricted Stock Units | |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. | 19 Aug 2021 | 13,164 | 31,584 | - | 3.1 | 40,413 | Common Stock |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 10,496 | 26,101 | - | - | Restricted Stock Units | |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 7,502 | 33,603 | - | - | Restricted Stock Units | |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 148,800 | 148,800 | - | - | Employee Stock Option (Right to buy) | |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 143,840 | 143,840 | - | - | Employee Stock Option (Right to buy) | |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 49,600 | 49,600 | - | - | Employee Stock Option (Right to buy) | |
| NRX Pharmaceuticals Inc | Alessandra Daigneault | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 6,320 | 6,320 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges